Ionis Pharmaceuticals IONS Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's effective income tax rate reconciliation, tax credit, research, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's effective income tax rate reconciliation, tax credit, research, amount?
- Ionis Pharmaceuticals (IONS) reported effective income tax rate reconciliation, tax credit, research, amount of $4.44M in Q4 2025.
- What does effective income tax rate reconciliation, tax credit, research, amount mean?
- The total value of tax credits claimed for research and development activities.
- How do you interpret effective income tax rate reconciliation, tax credit, research, amount?
- Higher values indicate a strong commitment to R&D and effective utilization of government innovation incentives.
- How does effective income tax rate reconciliation, tax credit, research, amount compare across companies?
- Widely used by pharmaceutical and technology companies to offset tax liabilities through R&D investment.